tubercidin has been researched along with Aura in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bigej, R; Boison, D; Friedman, JL; Saleumvong, B; Sandau, US; Yahya, M | 1 |
| Faingold, CL; Kommajosyula, SP; Randall, ME | 1 |
| Boison, D; Li, T; Shen, HY | 1 |
3 other study(ies) available for tubercidin and Aura
| Article | Year |
|---|---|
Transient use of a systemic adenosine kinase inhibitor attenuates epilepsy development in mice.
Topics: Adenosine Kinase; Animals; Anticonvulsants; Brain; Enzyme Inhibitors; Epilepsy; Male; Mice; Mice, Inbred C57BL; Tubercidin | 2019 |
Inhibition of adenosine metabolism induces changes in post-ictal depression, respiration, and mortality in genetically epilepsy prone rats.
Topics: Adenine; Adenosine; Animals; Blood Gas Analysis; Brugada Syndrome; Disease Models, Animal; Enzyme Inhibitors; Epilepsy; Female; Genetic Predisposition to Disease; Incidence; Male; Oxygen; Rats; Respiration; Respiration Disorders; Seizures; Sex Characteristics; Tubercidin | 2016 |
A novel mouse model for sudden unexpected death in epilepsy (SUDEP): role of impaired adenosine clearance.
Topics: Adenine; Adenosine; Adenosine Deaminase Inhibitors; Adenosine Kinase; Animals; Caffeine; Cause of Death; Death, Sudden; Disease Models, Animal; Enzyme Inhibitors; Epilepsy; Kainic Acid; Mice; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Risk Factors; Seizures; Survival Analysis; Tubercidin | 2010 |